ALMAS MOMIN: Open Payments
NPI 1073918280 · LILBURN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 27 payments from 15 companies in 2025. Trend: 2023 $806 · 2024 $617 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $83 |
| Astellas Pharma US Inc | 3 | $71 |
| Lilly USA, LLC | 3 | $60 |
| SANOFI-AVENTIS U.S. LLC | 3 | $59 |
| Novo Nordisk Inc | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| ABBVIE INC. | 2 | $29 |
| Insulet Corporation | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: Veozah, TZIELD, MOUNJARO, PAXLOVID, PREVNAR 20, CAPLYTA, QULIPTA, Omnipod.
Industry payments across GA — which companies pay providers there.
